| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/26/1995 | WO1995014109A1 High through-put quantitative polymerase chain reaction for hiv clinical specimens |
| 05/26/1995 | WO1995014108A1 Primer extension mass spectroscopy nucleic acid sequencing method |
| 05/26/1995 | WO1995014102A1 Recombinant viruses coding for thymidine kinase in gene therapy |
| 05/26/1995 | WO1995014101A1 Recombinant adenoviruses for gene therapy in cancers |
| 05/26/1995 | WO1995014100A2 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 05/26/1995 | WO1995014099A2 Process for protein production in plants |
| 05/26/1995 | WO1995014098A1 Chimeric regulatory regions and gene cassettes for expression of genes in plants |
| 05/26/1995 | WO1995014097A1 Cloning and expression cassette, expression vectors and transformed bacteria comprising the r. capsulatus frup promoter, and applications |
| 05/26/1995 | WO1995014096A1 Dna sequences encoding porcine pancreatic carboxypeptidase b |
| 05/26/1995 | WO1995014095A1 Endothelin-converting enzyme |
| 05/26/1995 | WO1995014094A1 Dna chain coding for glycero-3-phosphate acyltransferase and use thereof |
| 05/26/1995 | WO1995014093A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 05/26/1995 | WO1995014092A1 Dna, dna constructs, cells and plants derived therefrom |
| 05/26/1995 | WO1995014091A2 Compositions and methods for utilizing conditionally lethal genes |
| 05/26/1995 | WO1995014090A1 The human ep3 prostaglandin receptor |
| 05/26/1995 | WO1995014089A2 Cck-2, a receptor tyrosine kinase |
| 05/26/1995 | WO1995014088A1 Mck-10 (mammary carcinoma kinase), a receptor tyrosine kinase |
| 05/26/1995 | WO1995014087A1 Method for detecting charged oligonucleotides in biological fluids |
| 05/26/1995 | WO1995014086A1 Cartridge for preparing purified nucleic acids |
| 05/26/1995 | WO1995014085A2 A method for detection of alterations in the dna mismatch repair pathway |
| 05/26/1995 | WO1995014083A1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/26/1995 | WO1995014082A1 Delivery of gene products via mesangial cells |
| 05/26/1995 | WO1995014079A1 Myocardial grafts and cellular compositions useful for same |
| 05/26/1995 | WO1995014031A1 Chirally enriched synthetic phosphonate oligomers |
| 05/26/1995 | WO1995014030A1 Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages |
| 05/26/1995 | WO1995014028A2 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 05/26/1995 | WO1995013834A1 Chimeric oligonucleoside compounds |
| 05/26/1995 | WO1995013824A1 Method of treating renal disease by administering igf-i and igfbp-3 |
| 05/26/1995 | WO1995013823A1 Method of treating neurological disorders |
| 05/26/1995 | WO1995013767A1 Osteogenic product and process |
| 05/26/1995 | WO1995013701A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | WO1995011977A3 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
| 05/26/1995 | WO1994023027A3 Plant gene specifying acetyl coenzyme a carboxylase and transformed plants containing same |
| 05/26/1995 | CA2187152A1 Cck-2, a receptor tyrosine kinase |
| 05/26/1995 | CA2176819A1 A method for detection of alterations in the dna mismatch repair pathway |
| 05/26/1995 | CA2176808A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 05/26/1995 | CA2176709A1 Method of treating renal disease by administering igf-i and igfbp-3 |
| 05/26/1995 | CA2176708A1 Method of treating neurological disorders |
| 05/26/1995 | CA2176585A1 Recombinant adenoviruses for gene therapy in cancers |
| 05/26/1995 | CA2176575A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | CA2176507A1 Endothelin-converting enzyme |
| 05/26/1995 | CA2176372A1 Chirally enriched synthetic phosphonate oligomers |
| 05/26/1995 | CA2176341A1 Method for detecting charged oligonucleotides in biological fluids |
| 05/26/1995 | CA2176259A1 Chimeric oligonucleoside compounds |
| 05/26/1995 | CA2176256A1 Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages |
| 05/26/1995 | CA2176014A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 05/26/1995 | CA2175834A1 Dna sequences encoding porcine pancreatic carboxypeptidase b |
| 05/26/1995 | CA2174860A1 Myocardial grafts and cellular compositions useful for same |
| 05/26/1995 | CA2153482A1 Delivery of gene products via mesangial cells |
| 05/24/1995 | EP0654532A1 Antimucoglycoprotein monoclonal antibody |
| 05/24/1995 | EP0654531A1 ADP glucose-pyrophosphorylase |
| 05/24/1995 | EP0654530A2 Ubiquitin carrier enzyme E2-F1, purification, production and use |
| 05/24/1995 | EP0654529A1 $g(a)-2,8-SIALYLTRANSFERASE |
| 05/24/1995 | EP0654268A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 05/24/1995 | EP0654095A1 Electrophoresis of nucleic acid fragments |
| 05/24/1995 | EP0654093A1 Detecting and amplifying target nucleic acids using exonucleolytic activity |
| 05/24/1995 | EP0654092A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 05/24/1995 | EP0654089A1 Recombinant equine herpesviruses |
| 05/24/1995 | EP0654086A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 05/24/1995 | EP0654084A1 Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum |
| 05/24/1995 | EP0654083A1 Ptp-d subfamily of protein tyrosine phosphatases |
| 05/24/1995 | EP0654082A1 CLONING AND EXPRESSION OF A HUMAN $g(a)(1,3)FUCOSYLTRANSFERASE, FUCT-VI |
| 05/24/1995 | EP0654081A1 Hypoglycosylated recombinant glucosidase oxidases. |
| 05/24/1995 | EP0654080A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
| 05/24/1995 | EP0654077A1 Method and reagent for treatment of animal diseases |
| 05/24/1995 | EP0654076A1 Insect diagnostic and control compositions |
| 05/24/1995 | EP0654075A1 New bacillus thuringiensis strains and their insecticidal proteins |
| 05/24/1995 | EP0653943A1 Targeting somatic gene therapy to joints |
| 05/24/1995 | EP0653940A1 Glial mitogenic factors, their preparation and use |
| 05/24/1995 | EP0612207A4 Protection of plants against plant pathogens. |
| 05/24/1995 | EP0604560A4 Human cyclin e. |
| 05/24/1995 | EP0549706B1 Cationic charge modified microporous membranes |
| 05/24/1995 | EP0520029B1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 05/24/1995 | EP0447468B1 Ancrod proteins, their production and use |
| 05/24/1995 | EP0440709B1 Thrombolytic agents with modified kringle domains |
| 05/24/1995 | EP0398997B1 Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses |
| 05/24/1995 | EP0377676B1 Human erythroid-specific transcriptional enhancer |
| 05/24/1995 | EP0357767B1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
| 05/24/1995 | DE4423022C1 Transgenic plants with increased content of resistance factor |
| 05/24/1995 | CA2136381A1 Vector vaccines of bovine herpesvirus 1 |
| 05/23/1995 | US5418221 Composition containing enamel matrix from tooth germs for inducing binding between living mineralized tissue parts |
| 05/23/1995 | US5418159 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 05/23/1995 | US5418158 Tissue plasminogen activator-type |
| 05/23/1995 | US5418157 Recombinant 68,000 dalton collagenase of Clostridium histolyticum |
| 05/23/1995 | US5418155 Bioluminescence |
| 05/23/1995 | US5418153 Brome mosaic virus |
| 05/23/1995 | US5418150 Method of cleaving DNA |
| 05/23/1995 | US5418149 Reduction of non-specific amplification glycosylase using DUTP and DNA uracil |
| 05/23/1995 | US5418147 Glycosyl-phosphatidylinositol-specific phospholipase D |
| 05/23/1995 | US5418135 Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists |
| 05/23/1995 | US5418134 Immunoglobulin or T-receptor gene segments |
| 05/23/1995 | US5418132 Genetically engineered cell line for detecting infectious herpes simplex virus and method therefore |
| 05/23/1995 | US5417978 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 05/23/1995 | US5417971 Vaccines for Actinobacillus pleuropneumoniae |
| 05/23/1995 | EP0673423A4 Viral resistance by plant transformation with a replicase portion of a plant virus genome. |
| 05/23/1995 | CA1335663C Fish vaccine |
| 05/23/1995 | CA1335661C Non-reverting shigella live vaccines |
| 05/23/1995 | CA1335658C Process for preparing l-tertiary-leucine and l-phosphinothricine by transamination |
| 05/23/1995 | CA1335657C Three-dimensional cell and tissue culture system |
| 05/23/1995 | CA1335656C Luminescent chimeric proteins |